Assembly Biosciences Inc
NASDAQ:ASMB

Watchlist Manager
Assembly Biosciences Inc Logo
Assembly Biosciences Inc
NASDAQ:ASMB
Watchlist
Price: 14.17 USD -0.07%
Market Cap: 106.3m USD

Relative Value

The Relative Value of one ASMB stock under the Base Case scenario is 19.58 USD. Compared to the current market price of 14.17 USD, Assembly Biosciences Inc is Undervalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ASMB Relative Value
Base Case
19.58 USD
Undervaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
55
vs Industry
73
Median 3Y
3.4
Median 5Y
4.1
Industry
6.9
Forward
3.3
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-1.5
Industry
22.4
Forward
-2.4
vs History
vs Industry
16
Median 3Y
-0.8
Median 5Y
-1.1
Industry
19.1
vs History
vs Industry
13
Median 3Y
-0.7
Median 5Y
-1
Industry
23.2
vs History
6
vs Industry
32
Median 3Y
1.1
Median 5Y
0.9
Industry
2.5
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-2.3
Industry
7.5
Forward
-0.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.9
vs History
65
vs Industry
24
Median 3Y
0.2
Median 5Y
0.3
Industry
4
Forward
0.1
vs History
65
vs Industry
22
Median 3Y
0.2
Median 5Y
0.3
Industry
3.7
Forward
0.1
vs History
57
vs Industry
33
Median 3Y
0.2
Median 5Y
0.2
Industry
4.5
vs History
57
vs Industry
30
Median 3Y
0.2
Median 5Y
0.2
Industry
3.4
vs History
vs Industry
31
Median 3Y
-2.2
Median 5Y
-0.9
Industry
4.6

Multiples Across Competitors

ASMB Competitors Multiples
Assembly Biosciences Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Assembly Biosciences Inc
NASDAQ:ASMB
105.7m USD 3.7 -2.6 0.1 0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 35 047 871.8 -166 577.3 -202 278 -199 969.8
US
Abbvie Inc
NYSE:ABBV
348B USD 6.2 81.9 16.2 24.4
US
Amgen Inc
NASDAQ:AMGN
150B USD 4.5 36.6 15.1 26.8
US
Gilead Sciences Inc
NASDAQ:GILD
128.5B USD 4.5 267.7 10.6 13.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.1B USD 11.8 -242.2 26.4 27.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 010.1 -512.9 -558.5 -543.6
AU
CSL Ltd
ASX:CSL
124.3B AUD 5.3 29.2 17.9 22.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
66.7B USD 4.7 15.1 9.6 10.7
US
Seagen Inc
F:SGT
39.3B EUR 19.4 -59.4 -63.9 -57.7
NL
argenx SE
XBRU:ARGX
35.1B EUR 18.2 47.7 -2 697.2 -1 808.3
P/S Multiple
Revenue Growth P/S to Growth
US
Assembly Biosciences Inc
NASDAQ:ASMB
Average P/S: 3 186 360
3.7
29%
0.1
FR
Pharnext SCA
OTC:PNEXF
35 047 871.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.2
7%
0.9
US
Amgen Inc
NASDAQ:AMGN
4.5
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.5
3%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.8
10%
1.2
US
E
Epizyme Inc
F:EPE
2 010.1
N/A N/A
AU
CSL Ltd
ASX:CSL
5.3
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.7
6%
0.8
US
S
Seagen Inc
F:SGT
19.4
30%
0.6
NL
argenx SE
XBRU:ARGX
18.2
39%
0.5
P/E Multiple
Earnings Growth PEG
US
Assembly Biosciences Inc
NASDAQ:ASMB
Average P/E: 79.7
Negative Multiple: -2.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -166 577.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.9
87%
0.9
US
Amgen Inc
NASDAQ:AMGN
36.6
44%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
267.7
187%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.2 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -512.9 N/A N/A
AU
CSL Ltd
ASX:CSL
29.2
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
10%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A N/A
NL
argenx SE
XBRU:ARGX
47.7
28%
1.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Assembly Biosciences Inc
NASDAQ:ASMB
Average EV/EBITDA: 13.7
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -202 278 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.2
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
15.1
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.6
7%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.4
18%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -558.5 N/A N/A
AU
CSL Ltd
ASX:CSL
17.9
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
9.6
14%
0.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -63.9 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -2 697.2 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Assembly Biosciences Inc
NASDAQ:ASMB
Average EV/EBIT: 17.9
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 969.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24.4
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
26.8
31%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
13.2
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -543.6 N/A N/A
AU
CSL Ltd
ASX:CSL
22.4
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.7
13%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -1 808.3 N/A N/A